DNA vaccines against dengue virus based on the ns1 gene: The influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice

Virology

Volumn 358, Issue 2, 2007, Pages 413-423

  Costa, S M ^a   Azevedo, A S ^a   Paes, M V ^a   Sarges, F S ^a   Freire, M S ^b   Alves, A M B ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Department of Research and Development   (Brazil)

Author keywords

Challenge; Dengue virus; DNA vaccine; Mouse; NS1

Indexed keywords

DNA VACCINE; GLYCOPROTEIN E; PCENS1 VACCINE; PCENS1ANC VACCINE; PCTPANS1 VACCINE; PCTPANS1ANC VACCINE; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; IMMUNE RESPONSE; IMMUNITY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; DENGUE; DENGUE VACCINES; DENGUE VIRUS; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; PLASMIDS; PLASMINOGEN ACTIVATORS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

ANIMALIA; DENGUE VIRUS; MUS;

EID: 33846440866     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.08.052     Document Type: Article

References (40)

1. Alves A.M.B., Lásaro M.O., Almeida D.F., and Ferreira L.C.S. Epitope specificity of antibodies raised against enterotoxigenic Escherichia coli CFA/I fimbriae in mice immunized with naked DNA. Vaccine 16 (1998) 9-15
2. Alves A.M.B., Lásaro M.O., Almeida D.F., and Ferreira L.C.S. Immunoglobulin G subclass responses in mice immunized with plasmid DNA encoding the CFA/I fimbria of enterotoxigenic Escherichia coli. Immunol. Lett. 62 (1998) 145-149
3. Alves A.M.B., Lásaro M.O., Almeida D.F., and Ferreira L.C.S. New vaccine strategies against enterotoxigenic Escherichia coli. I: DNA vaccines against the CFA/I fimbrial adhesin. Braz. J. Med. Biol. Res. 32 (1999) 223-229
4. Alves A.M.B., Lásaro M.O., Almeida D.F., and Ferreira L.C. DNA immunisation against the CFA/I fimbriae of enterotoxigenic Escherichia coli (ETEC). Vaccine 19 (2001) 788-795
5. Ashok M.S., and Rangarajan P.N. Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model. Vaccine 20 (2002) 1563-1570
6. Brinton M.A., Kurane I., Mathew A., Zeng L., Shi P.Y., Rothman A., and Ennis F.A. Immune mediated and inherited defences against flaviviruses. Clin. Diagn. Virol. 10 (1998) 129-139
7. Caufour P.S., Motta M.C.A., Yamamura A.M.Y., Vazques S., Ferreira I.I., Jabor A.V., Bonaldo M.C., Freire M.S., and Galler R. Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses. Virus Res. 79 (2001) 1-14
8. Chambers T.J., Hahn C.S., Galler R., and Rice C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44 (1990) 649-688
9. Chung K.M., Nyabakken G.E., Thompson B.S., Engle M.J., Marri A., Fremont D.H., and Diamond M.S. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J. Virol. 80 (2006) 1340-1351
10. Costa S.M., Freire M.S., and Alves A.M.B. DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus. Vaccine 24 (2006) 4562-4564
11. Costa S.M., Paes M.V., Barreto D.F., Pinhao A.T., Barth O.M., Queiroz J.L., Armoa G.R., Freire M.S., and Alves A.M.B. Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence. Vaccine 24 (2006) 195-205
12. Donnelly J.J., Wahren B., and Liu M.A. DNA vaccines: progress and challenges. J. Immunol. 175 (2005) 633-639
13. Edelman R. Dengue and dengue vaccines. J. Infect. Dis. 191 (2005) 650-653
14. Erhardt W., Hebestedt A., Aschenbrenner G., Pichotka B., and Blumel G. A comparative study with various anesthetics in mice (pentobarbitone, ketamine-xylazine, carfentanyl-etomidate). Res. Exp. Med. (Berl) 184 (1984) 159-169
15. Falgout B., Chanock R., and Lai C.J. Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J. Virol. 63 (1989) 1852-1860
16. Falgout B., Bray M., Schlesinger J.J., and Lai C.J. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J. Virol. 64 (1990) 4356-4363
17. Flamand M., Megret F., Mathieu M., Lepault J., Rey F.A., and Deubel V. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J. Virol. 73 (1999) 6104-6110
18. Guzmán C.A., and Kourí G. Dengue: an update. Lancet Infect. Dis. 2 (2002) 33-42
19. Halstead S.B., and Deen J. The future of dengue vaccines. Lancet 360 (2002) 1243-1245
20. Halstead S.B., and O'Rourke E.J. Dengue viruses and mononuclear phagocytes I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146 (1977) 201-229
21. Henchal E.A., Henchal L.S., and Schlesinger J.J. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J. Gen.Virol. 69 Pt 8 (1988) 2101-2107
22. Irie K., Mohan P.M., Sasaguri Y., Putnak R., and Padmanabhan R. Sequence analysis of cloned dengue virus type 2 genome (New guinea-C strain). Gene 75 (1989) 197-211
23. Jacobs M.G., Robinson P.J., Bletchly C., Mackenzie J.M., and Young P.R. Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J. 14 (2000) 1603-1610
24. Kinney R.M., and Huang C.Y.H. Development of new vaccines against dengue fever and Japanese encephalitis. Intervirology 144 (2001) 176-197
25. Leatherbarrow R.M., and Dwek R.A. Binding of complement subcomponent C1q to mouse IgG1 m IgG2a and IgG2b: a novel C1q binding assay. Mol. Immunol. 21 (1984) 321-327
26. Li Z., Howard A., Kelley C., Delogu G., Collins F., and Morris S. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect. Immun. 67 (1999) 4780-4786
27. Lin Y.L., Chen L.K., Liao C.L., Yeh C.T., Ma S.H., Chen J.L., Huang Y.L., Chen S.S., and Chang H.Y. DNA immunization with Japanese Encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J. Virol. 72 (1998) 191-200
28. Lindenbach B.D., and Rice C.M. Flaviviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott Williams and Wilkins, Philadelphia 991-1041
29. Lu Y., Raviprakash K., Leao I.C., Chikhlikar P.R., Ewing D., Anwar A., Chougnet C., Murphy G., Hayes C.G., August T.J., and Marques Jr. E.T. Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies. Vaccine 21 (2003) 2178-2189
30. Lucisano Y.M., and Lachmann P.J. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Clin. Exp. Immunol. 84 (1991) 1-8
31. Mackenzie J.M., Jones M.K., and Young P.R. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220 (1996) 232-240
32. Pryor M.J., and Wright P.J. The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus. Virology 194 (1993) 769-780
33. Pryor M.J., and Wright P.J. Glycosylation mutants of dengue virus NS1 protein. J. Gen.Virol. 75 Pt 5 (1994) 1183-1187
34. Rothman A.L. Dengue: defining protective versus pathologic immunity. J. Clin. Invest. 113 (2004) 946-951
35. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory Press, New York
36. Schlesinger J.J., Brandriss M.W., and Walsh E.E. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J. Gen. Virol. 68 (1987) 853-857
37. Schlesinger J.J., Foltzer M., and Chapman S. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192 (1993) 132-141
38. Winkler G., Maxwell S.E., Ruemmler C., and Stollar V. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 171 (1989) 302-305
39. Wu S.F., Liao C.L., Lin Y.L., Yeh C.T., Chen L.K., Huang Y.F., Chou H.Y., Huang J.L., Shaio M.F., and Sytwu H.K. Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice. Vaccine 21 (2003) 3919-3929
40. Young P.R., Hilditch P.A., Bletchly C., and Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J. Clin. Microbiol. 38 (2000) 1053-1057